# Ezetimibe Plus Atorvastatin Versus Atorvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03406)

> **NCT00651404** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 137 (actual)

## Conditions studied

- Hypercholesterolemia
- Atherosclerosis

## Interventions

- **DRUG:** Ezetimibe
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00651404
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2004-12
- **Final completion:** 2004-12
- **Target enrollment:** 137 (ACTUAL)
- **Last updated:** 2022-02-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00651404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00651404, "Ezetimibe Plus Atorvastatin Versus Atorvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03406)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00651404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*